A phase III, randomized, double-blind, multi-center, placebo-controlled, parallel-group, safety and efficacy study of SPD465 in adults with attention-deficit hyperactivity disorder (ADHD).
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Mixed amfetamine salts (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Registrational; Therapeutic Use
- Sponsors Shire
- 30 Sep 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History